Viewing Study NCT07018050


Ignite Creation Date: 2025-12-24 @ 4:46 PM
Ignite Modification Date: 2026-01-01 @ 4:49 PM
Study NCT ID: NCT07018050
Status: RECRUITING
Last Update Posted: 2025-09-22
First Post: 2025-06-04
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Phase II Study of QLS32015 Combination Therapy in the Treatment of Multiple Myeloma
Sponsor: Qilu Pharmaceutical Co., Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module